Effect of Rudanti in Pulmonary tuberculosis

Clinical study on RasÄ?yaá¹?a activity of RudantÄ« (Capparis moonii Wight.) in the management of RÄ?jayaká¹£mÄ? (Pulmonary tuberculosis). - RRPT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015173

Enrollment

100

Registered

2018-08-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: Dr Lalit Nagar: PhD Scholar Dept. of Dravyaguna Faculty of Ayurveda IMS, BHU Varanasi Intervention2: Rudanti Fruit Power, Anti tubercular Treatment (ATT) for six months: Source of Rudan

Eligibility

Inclusion criteria

Inclusion criteria: 1- Diagnosed cases of sputum negative and sputum positive Pulmonary Tuberculosis patients of either sex. 2- Relapse cases. 3- Failure cases. 4- Age 20-70 year. 5- Pulmonary tuberculosis patients with mild pulmonary infusion.

Exclusion criteria

Exclusion criteria: 1- Age below 20 year and above 70 year. 2- Extra pulmonary tuberculosis. 3- HIV and Tuberculosis co-infect. 4- MDR Tuberculosis patients. 5- Severely ill patients. 6- Pregnant patients.

Design outcomes

Primary

Measure	Time frame
Sputum for AFB Negative Decreased in cavities seen on chest radiographTimepoint: 6 months 6 months	—

Secondary

Measure	Time frame
Increase in total body weight Increase in Appetite Timepoint: 3 months 3 months	—

Countries

India

Contacts

Public ContactLALIT NAGAR

Banaras Hindu University

kndbhu@gmail.com09646170067

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026